World’s First Commercial iPSC Cell Plant Opens in Japan
Jim Daley | Mar 23, 2018
The $340 million, 30,000-square-foot center will produce cells for therapeutic applications.
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.
Image of the Day: Brand New Bowel
The Scientist Staff, The Scientist Staff | Oct 13, 2017
Using human stems cells and segments of rat intestines, scientists engineer bowels that are capable of absorbing nutrients.
Image of the Day: Lab-Grown Brain
The Scientist Staff, The Scientist Staff | Oct 12, 2017
Scientists grew organoids that mimic human fetal brains and infected them with the Zika virus to model its neurological effects.
Image of the Day: Liver Buds
The Scientist Staff | Jun 16, 2017
Using human induced pluripotent stem cells, scientists grew liver organoids and studied gene expression patterns in individual cells to learn more about how these tissues develop.